An Adaptive Dose-Finding Design Based on Both Safety and Immunologic Responses in Cancer Clinical Trials
From MaRDI portal
Publication:123055
DOI10.1080/19466315.2018.1462727WikidataQ90325324 ScholiaQ90325324MaRDI QIDQ123055
Cody Chiuzan, Elizabeth Garrett-Mayer, Michael I. Nishimura
Publication date: 3 July 2018
Published in: Statistics in Biopharmaceutical Research (Search for Journal in Brave)
Related Items (1)
This page was built for publication: An Adaptive Dose-Finding Design Based on Both Safety and Immunologic Responses in Cancer Clinical Trials